Amyloid oligomers of p53 mutants are very common in cancer cells and are associated with tumor malignant phenotypes such as chemoresistance and tumor growth (Ano Bom et al., 2012; de Oliveira et al., 2020; Pedrote et al., 2020). This evidence concerns the gene TP53 and neoplasm.